Hood, Caleb J.
Hendren, Nicholas S.
Pedretti, Rose
Roth, Lori R.
Saelices, Lorena
Grodin, Justin L.
Funding for this research was provided by:
NHLBI Division of Intramural Research (R01HL160892)
Article History
Accepted: 20 July 2022
First Online: 5 August 2022
Declarations
:
: Justin Grodin received research funding from the Texas Health Resources Clinical Scholarship and the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R01HL160892 and receives consulting income from Pfizer and Eidos Therapeutics. Caleb Hood declares no conflict of interest. Nicholas Hendren declares no conflict of interest. Rose Pedretti declares no conflict of interest. Lorena Saelices declares no conflict of interest. Lori Roth has done consulting work with Eidos Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.